Effective high-dose methotrexate toxicity reversal using fixed-dose glucarpidase in obese patients: a case series. [PDF]
J Med Case RepGrofvert J +4 more
europepmc +1 more source
The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. [PDF]
J Clin InvestKager L, Boztug K.
europepmc +1 more source
SGLT2 Inhibitors in Mitigating Cancer Therapy-Related Cardiac Dysfunction: Expanding the Evidence. [PDF]
JACC CardioOncolDabour MS, Blaes AH, Ramu B, Zordoky BN.
europepmc +1 more source
Charting the Current Landscape and Future Prospects of Cancer Therapy-Related Cardiovascular Toxicity in Cancer Survivors: From Bench to Bedside. [PDF]
Drug Des Devel TherTao S, Yu L, Zhang L, Li J, Wu J, Tan Y.
europepmc +1 more source
Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis. [PDF]
CardiooncologyEl-Helbawy A +6 more
europepmc +1 more source
Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society. [PDF]
CardiooncologyKeramida K +10 more
europepmc +1 more source
Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase. [PDF]
BMJ Case RepPurzycki T, Knapp M, Patel S.
europepmc +1 more source
Trends in the Dispensing of Oral Anti-Cancer Medications Across Australia Over 10 Years. [PDF]
Pharmacoepidemiol Drug SafLeach MJ +5 more
europepmc +1 more source
Recurrent cytarabine-induced sinus bradycardia in a patient with acute myeloid leukemia: a case report and review of the literature. [PDF]
J Med Case RepTesfaye T +5 more
europepmc +1 more source
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation [PDF]
, 2016 Jakub Neradil +3 more
core +1 more source